search
Back to results

Ceramide Containing Multivesicular Emulsion Application . . .

Primary Purpose

Foot Transepidermal Water Loss in Patients in NIDDM, Foot Dryness in Patients With NIDDM

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
CeraVe
Sponsored by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Foot Transepidermal Water Loss in Patients in NIDDM

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • >18 years of age
  • non insulin-dependent diabetes
  • moderate to severe xerosis of both feet [a score of at least 4 on a scale of 0 (normal) to 8 (deep fissuring)]
  • capable of understanding and signing consent form

Exclusion Criteria:

  • history of ichthyosis vulgaris
  • known hypersensitivity to the topical product used in the study
  • previous use of high potency steroids (class I and II) in past 2 week
  • presence of acute skin disease or infection, such as vasculitis or cellulitis
  • presence of foot ulcer
  • evidence of gangrene

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Decrease transepidermal water loss and foot dryness in study subjects.

    Secondary Outcome Measures

    Full Information

    First Posted
    July 27, 2009
    Last Updated
    April 18, 2011
    Sponsor
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00947726
    Brief Title
    Ceramide Containing Multivesicular Emulsion Application . . .
    Official Title
    Ceramide Containing Multivesicular Emulsion Application as a Skin Hydration Treatment for Feet of Subjects With Non-insulin Dependent Diabetes Mellitus.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2011
    Overall Recruitment Status
    Completed
    Study Start Date
    July 2009 (undefined)
    Primary Completion Date
    October 2009 (Actual)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Name of the Sponsor
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    We believe that using a ceramide based foot cream two times a day for two weeks will prevent water loss and overall foot dryness in patients with non-insulin dependent diabetes.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Foot Transepidermal Water Loss in Patients in NIDDM, Foot Dryness in Patients With NIDDM

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    30 (Anticipated)

    8. Arms, Groups, and Interventions

    Intervention Type
    Drug
    Intervention Name(s)
    CeraVe
    Other Intervention Name(s)
    Ceramide based foot cream
    Intervention Description
    Using OTC cream on foot twice daily for two weeks.
    Primary Outcome Measure Information:
    Title
    Decrease transepidermal water loss and foot dryness in study subjects.
    Time Frame
    5 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: >18 years of age non insulin-dependent diabetes moderate to severe xerosis of both feet [a score of at least 4 on a scale of 0 (normal) to 8 (deep fissuring)] capable of understanding and signing consent form Exclusion Criteria: history of ichthyosis vulgaris known hypersensitivity to the topical product used in the study previous use of high potency steroids (class I and II) in past 2 week presence of acute skin disease or infection, such as vasculitis or cellulitis presence of foot ulcer evidence of gangrene

    12. IPD Sharing Statement

    Learn more about this trial

    Ceramide Containing Multivesicular Emulsion Application . . .

    We'll reach out to this number within 24 hrs